|
Dr. Hunziker was elected director of Genentech in April 2004. He joined the Roche Group as chief financial officer in 2001 and was elected to the Executive Committee of the Roche Group at that time. In January 2005 he was appointed deputy head of the Executive Committee. Prior to joining the Roche Group from 1998 until 2001 Dr. Hunziker was chief executive officer of the Diethelm Group and Diethelm Keller Holding Ltd. Dr. Hunziker joined Corange Ltd (holding company of Boehringer Mannheim Group) where he was appointed chief financial officer in 1997. Dr. Hunziker is also a member of the Boards of Directors of Holcim Ltd. and Chugai Pharmaceutical Co. Ltd. a subsidiary of Roche. Pursuant to the affiliation agreement Dr. Hunziker is a designee of Roche. | 